Legend Biotech Corp. (LEGN), Monday announced the appointment of Carlos Santos as the company's Chief Financial Officer, effective immediately.
Santos will succeed Jessie Yeung, who has served as the interim CFO since January 2025.
Prior to joining Legend Biotech, Santos was CFO for U.S. Oncology at AstraZeneca.
""Legend has established itself as a leader in cell therapy innovation, and I look forward to working alongside this talented executive team to continue building on the Company's strong foundation," Santos commented.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.